122 related articles for article (PubMed ID: 1989796)
1. Amiodarone-induced pulmonary toxicity. Immunoallergologic tests and bronchoalveolar lavage phospholipid content.
Nicolet-Chatelain G; Prevost MC; Escamilla R; Migueres J
Chest; 1991 Feb; 99(2):363-9. PubMed ID: 1989796
[TBL] [Abstract][Full Text] [Related]
2. Cytology of bronchoalveolar lavage in some rare pulmonary disorders: pulmonary alveolar proteinosis and amiodarone pulmonary toxicity.
Mermolja M; Rott T; Debeljak A
Cytopathology; 1994 Feb; 5(1):9-16. PubMed ID: 8173037
[TBL] [Abstract][Full Text] [Related]
3. Bronchoalveolar lavage cell count and differential are not reliable indicators of amiodarone-induced pneumonitis.
Ohar JA; Jackson F; Dettenmeier PA; Bedrossian CW; Tricomi SM; Evans RG
Chest; 1992 Oct; 102(4):999-1004. PubMed ID: 1395816
[TBL] [Abstract][Full Text] [Related]
4. Amiodarone pulmonary toxicity: cytopathology, ultrastructure, and immunocytochemistry.
Bedrossian CW; Warren CJ; Ohar J; Bhan R
Ann Diagn Pathol; 1997 Oct; 1(1):47-56. PubMed ID: 9869825
[TBL] [Abstract][Full Text] [Related]
5. Amiodarone pulmonary toxicity: a multidisciplinary review of current status.
Fraire AE; Guntupalli KK; Greenberg SD; Cartwright J; Chasen MH
South Med J; 1993 Jan; 86(1):67-77. PubMed ID: 8420020
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects.
Martin WJ; Standing JE
J Pharmacol Exp Ther; 1988 Feb; 244(2):774-9. PubMed ID: 3346847
[TBL] [Abstract][Full Text] [Related]
7. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 2).
Martin WJ; Rosenow EC
Chest; 1988 Jun; 93(6):1242-8. PubMed ID: 3286141
[TBL] [Abstract][Full Text] [Related]
8. [Cytologic changes in bronchoalveolar lavage in amiodarone treated patients].
Jolly E; Belloti MS; Lowenstein J; Luna C; Avagnina A; Elsner B; Mazzei JA
Medicina (B Aires); 1991; 51(1):19-25. PubMed ID: 1921687
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone-induced pulmonary inflammation. Correlation with drug dose and lung levels of drug, metabolite, and phospholipid.
Wilson BD; Clarkson CE; Lippmann ML
Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1110-4. PubMed ID: 2024822
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity.
Kang IS; Kim KJ; Kim Y; Park SH
Korean J Intern Med; 2014 Nov; 29(6):746-53. PubMed ID: 25378973
[TBL] [Abstract][Full Text] [Related]
11. Phospholipid content of bronchoalveolar lavage fluid in granite workers with silicosis in Quebec.
Bégin R; Lesur O; Bouhadiba T; Guojian L; Larivée P; Melloni B; Martel M; Cantin A
Thorax; 1993 Aug; 48(8):840-4. PubMed ID: 8211875
[TBL] [Abstract][Full Text] [Related]
12. [Late postoperative amiodarone pulmonary toxicity].
Alonso-Fernández A; Alvarez-Sala R; Mediano O; Torres I; Moreno I
An Med Interna; 2003 Aug; 20(8):419-20. PubMed ID: 14516264
[TBL] [Abstract][Full Text] [Related]
13. Acute silica toxicity: attenuation by amiodarone-induced pulmonary phospholipidosis.
Antonini JM; McCloud CM; Reasor MJ
Environ Health Perspect; 1994 Apr; 102(4):372-8. PubMed ID: 7925177
[TBL] [Abstract][Full Text] [Related]
14. Clinical aspects of amiodarone pulmonary toxicity.
Kennedy JI
Clin Chest Med; 1990 Mar; 11(1):119-29. PubMed ID: 2182273
[TBL] [Abstract][Full Text] [Related]
15. Amiodarone pulmonary toxicity: functional and ultrastructural evaluation.
Liu FL; Cohen RD; Downar E; Butany JW; Edelson JD; Rebuck AS
Thorax; 1986 Feb; 41(2):100-5. PubMed ID: 3010484
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha alters phospholipid content in the bronchoalveolar lavage-accessible space of isolated perfused rat lungs.
Hertzog JH; Godinez MH; Godinez RI
Crit Care Med; 1994 Dec; 22(12):1969-75. PubMed ID: 7988135
[TBL] [Abstract][Full Text] [Related]
17. [Early diagnosis of amiodarone-induced pulmonary toxicity: are repeated lung function tests of any value?].
Ulrik CS; Aldershvile J
Ugeskr Laeger; 1996 Jun; 158(24):3445-7. PubMed ID: 8650812
[TBL] [Abstract][Full Text] [Related]
18. Initial characteristics and outcome of hospitalized patients with amiodarone pulmonary toxicity.
Mankikian J; Favelle O; Guillon A; Guilleminault L; Cormier B; Jonville-Béra AP; Perrotin D; Diot P; Marchand-Adam S
Respir Med; 2014 Apr; 108(4):638-46. PubMed ID: 24565600
[TBL] [Abstract][Full Text] [Related]
19. Rapid pulmonary phospholipid accumulation induced by intravenous amiodarone.
Lapinsky SE; Mullen JB; Balter MS
Can J Cardiol; 1993 May; 9(4):322-4. PubMed ID: 8513425
[TBL] [Abstract][Full Text] [Related]
20. Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone.
Yamada Y; Shiga T; Matsuda N; Hagiwara N; Kasanuki H
Circ J; 2007 Oct; 71(10):1610-6. PubMed ID: 17895560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
